Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.
(2026 Jun 7)
Nat Med
Kaplan LM, Startseva E, le Roux CW, Wharton S, Bozkurt B, Mazo DF, von Schlippenbach J, González Maldonado S, Ajaz Hussain S, Neff GW, Gonzalez Rojas Y, Smith C, Younes R, Sanyal AJ, SYNCHRONIZE-MASLD Investigators

Polymeric nanoparticles functionalized with peptides: Advanced strategies for crossing the blood-brain barrier.
(2026)
Adv Pharmacol 105(): 325-363
Llorente X, Esteruelas G, García ML, Souto EB, Sánchez-López E

Randomised controlled feasibility trial of an intervention to increase activity and reduce sedentary behaviour in people with severe mental illness: Walking fOR Health (WORtH) study.
(2026 Jun 7)
BMJ Open 16(6): e107567
McDonough SM, Dillon M, McDonough CM, McAuley J, Clarke M, Murphy C, Clarke M, McArdle D, Niven A, Williams J, Wilson I, Tully MA, Murphy MH, Howes SC

Efficacy of Upadacitinib for the Treatment Alopecia Areata: A Systematic Review and Meta-Analysis.
(2026 Jun 6)
J Am Acad Dermatol
Barnawi G, Lazarowitz R, Nukaly HY, Creighton R, Ridha Z, Aldein AS, Algaidi Y, Weiss E, Litvinov IV, Donovan J

Acceptability and preferences regarding RSV immunisation during pregnancy: a cross-sectional study in diverse global settings.
(2026 Jun 7)
Vaccine 88(): 128783
Favre G, Pfund A, Gerbier E, Anselem O, Balaya V, Ceccaldi PF, Chalouhi G, Ducarme G, Garabedian C, Guerby P, Mottet N, Picone O, Poncelet C, Quibel T, Sananes N, Sentilhes L, Simon J, Tran PL, Ville Y, Baud D, Blume C, Capoccia Brugger R, Farin A, Fougère Y, Fruscalzo A, Gallmann D, Haslinger C, Huber D, Martinez de Tejada B, Radan AP, Schäffer L, Todesco Bernasconi M, Vökt C, Miranda J, Nieto-Calvache AJ, Rivera-Torres LF, De Santis M, Kratochwila C, Paladini D, Tantari M, Ernst C, Mossong J, Murray J, Feuerschuette OHM, Luz AG, Surita F, Boucoiran I, Goncé A, Higgins M, Démolis R, Alexandre K, Pomar L

Show complete publication list

In the News